Ken Griffin Abbott Laboratories Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $11.3 Million - $12.6 Million	112,000 Added 8.41%	1,444,300 $150 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $63.8 Million - $70.5 Million	-582,600 Reduced 30.42%	1,332,300 $151 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $96.4 Million - $118 Million	1,068,900 Added 126.35%	1,914,900 $211 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $6.75 Million - $8.1 Million	70,700 Added 9.12%	846,000 $81.9 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $113 Million - $126 Million	-1,121,300 Reduced 59.12%	775,300 $84.5 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $41.3 Million - $48.7 Million	426,900 Added 29.05%	1,896,600 $192 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $33.1 Million - $38.8 Million	347,900 Added 31.01%	1,469,700 $161 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $986,952 - $1.14 Million	-10,200 Reduced 0.9%	1,121,800 $109 Million

3,135

1.33B

8.63M

7.17M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.